| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lexaria Bioscience Corp. (LEXX) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. LEXX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 273.5K | $166.8K | - | |
| CFO | 100.0K | $61.0K | - | |
| CEO | 65.0K | $39.6K | - | |
| Dir | 63.0K | $38.4K | - | |
| Dir | 43.0K | $26.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2016 | Docherty John Martin | President | Buy | 210,000 | $0.10 | $21,000.00 | +34.7% | |
| Sep 16, 2015 | McKechnie William Edward | Director | Buy | 100,000 | $0.19 | $19,000.00 | New | |
| Aug 17, 2015 | Docherty John Martin | President | Buy | 420,000 | $0.20 | $84,000.00 | +323.1% | |
| Jul 22, 2015 | Docherty John Martin | President | Buy | 500,000 | $0.17 | $85,000.00 | +384.6% | |
| May 15, 2015 | Docherty John Martin | President | Buy | 130,000 | $0.10 | $13,000.00 | New |